|
|
||||||||
1 The First Department of
Internal Medicine and 5 Department
of Clinical Preventive Medicine,
CD40-CD40 ligand (CD40L) interaction was
originally defined as important molecules for the development of
humoral immunity. Thereafter, some investigations have focused on its
essential roles for the induction of cell-mediated immunity in host
defenses. Here we investigated the antitumor activity of murine
alveolar macrophages through CD40-CD40L interaction. The
CD40L gene was transfected into murine lung cancer cells (3LLSA), and CD40L-expressing clones (3LLSA-CD40L) were established. Stimulation of CD40 molecules on
the surface of alveolar macrophages with 3LLSA-CD40L cells induced the
production of nitric oxide, tumor necrosis factor-
, and
interleukin-12 and the tumoricidal activity of alveolar macrophages in
the presence of interferon-
, which increased the surface expression of CD40 molecules on alveolar macrophages. These findings were not
observed when alveolar macrophages were obtained from CD40-deficient mice. On the other hand, interleukin-6 production by alveolar macrophages did not depend on CD40-CD40L interaction. We also established a murine melanoma cell line expressing CD40L (B16 4A5-CD40L) that could induce tumoricidal activity of alveolar macrophages. Furthermore, when spleen cells were cocultivated with
3LLSA-CD40L cells, specific cytotoxic T lymphocytes for wild-type 3LLSA
cells could be induced. These results suggest that
CD40L gene transfer into tumor cells
may induce antitumor immunity in a tumor-bearing host and may offer a
new strategy for cancer gene therapy.
nitric oxide; cytokine production; cytotoxic T lymphocyte; lung cancer; CD40-deficient mice
This article has been cited by other articles:
![]() |
T. Kikuchi, M. Maemondo, K. Narumi, K. Matsumoto, T. Nakamura, and T. Nukiwa Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells Blood, December 1, 2002; 100(12): 3950 - 3959. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Panjwani, L. Popova, and P. K. Srivastava Heat Shock Proteins gp96 and hsp70 Activate the Release of Nitric Oxide by APCs J. Immunol., March 15, 2002; 168(6): 2997 - 3003. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Barazzone Argiroffo, Y. R. Donati, J. Boccard, A. F. Rochat, C. Vesin, C.-D. Kan, and P.-F. Piguet CD40-CD40 Ligand Disruption Does Not Prevent Hyperoxia-Induced Injury Am. J. Pathol., January 1, 2002; 160(1): 67 - 71. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |